美股市场个股详情
PSTV Plus Therapeutics
- 2.2700
- +0.1400+6.57%
收盘价 05/08 16:00 (美东)
- 2.3000
- +0.0300+1.32%
盘后 19:06 (美东)
970.67万总市值-535市盈率TTM
2.4800最高价2.1000最低价23.49万股成交量2.1600今开2.1300昨收53.75万成交额5.57%换手率亏损市盈率(静)427.61万总股本4.450052周最高-7.21市净率956.47万流通值0.969452周最低--股息TTM421.35万流通股7507.4985历史最高--股息率TTM17.84%振幅0.9690历史最低2.2880平均价1股每手
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
Plus Therapeutics股票讨论区
NEWS
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
Plus Therapeutics, Inc. (Nasdaq: PSTV) will host an investor call on May 9th, 2024, to discuss the acquisition of CNSide assets and provide updates on the FORESEE clinical trial. The company aims to leverage the acquired assets for CNS cancers and share key insights with investors.
Positive
Strategic acquisition of C...
To bolster its financial position and further its research in targeted radiotherapeutics, Plus Therapeutics, Inc. (Nasdaq: PSTV), based out of Austin, Texas, has announced a substantial private placement financing agreement. The deal, set to raise up to approximately $18 million in gross proceeds, has been orchestrated with the support of ne...
NEWS
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
In an unprecedented move that signals a new era for cancer treatment, Plus Therapeutics, Inc., a trailblazer in the development of targeted radiotherapeutics, has been awarded a $3 million grant by the Department of Defense (DoD) through its Congressionally Directed Medical Research Programs (CDMRP). This s...
Benzinga· 3 mins ago
Salvation is coming, perhaps !
暂无评论